ReShape Lifesciences has received a Notice of Allowance from the U.S. Patent and Trademark Office for its patent application on a new Diabetes Neuromodulation system utilizing its vagal nerve block ...
CORAL SPRINGS, Fla., Jan. 12, 2026 /PRNewswire/ -- Neurolief Inc., a medical device company focused on neuromodulation therapies for neuropsychiatric conditions, today announced that the U.S. Food and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results